Top Markets
Coin of the day
Stimcell Energetics, Inc. Stimcell Energetics, Inc.

Stimcell Energetics, Inc.

STME
Kedudukan dalam Saham #34049
StimCell Energetics Inc. is a biotechnology company focused on the research,... StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Harga Saham
$0.3
Disegerakkan terakhir: 2026-08-13
Modal Pasaran
$6.34M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
5.26%
Negara
CA
Perdagangan Stimcell Energetics, Inc. (STME)

Kategori

EPS untuk Stimcell Energetics, Inc. (STME)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Stimcell Energetics, Inc., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Stimcell Energetics, Inc. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa